AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
Economic recentralization in Uzbekistan
Authors: Bartlett, DL
Citation: Dl. Bartlett, Economic recentralization in Uzbekistan, POST-SOV GE, 42(2), 2001, pp. 105-121
Role of tumor necrosis factor on toxicity and cytokine production after isolated hepatic perfusion
Authors: Lans, TE Bartlett, DL Libutti, SK Gnant, MFX Liewehr, DJ Venzon, DJ Turner, EM Alexander, HR
Citation: Te. Lans et al., Role of tumor necrosis factor on toxicity and cytokine production after isolated hepatic perfusion, CLIN CANC R, 7(4), 2001, pp. 784-790
Laparoscopic continuous hyperthermic peritoneal perfusion
Authors: Chang, E Alexander, HR Libutti, SK Hurst, R Zhai, SP Figg, WD Bartlett, DL
Citation: E. Chang et al., Laparoscopic continuous hyperthermic peritoneal perfusion, J AM COLL S, 193(2), 2001, pp. 225-229
A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases
Authors: Feldman, AL Alexander, HR Bartlett, DL Kranda, KC Miller, MS Costouros, NG Choyke, PL Libutti, SK
Citation: Al. Feldman et al., A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases, ANN SURG O, 8(9), 2001, pp. 741-745
Comparison of NIS and NHIS/NIPRCS vaccination coverage estimates
Authors: Bartlett, DL Ezzti-Rice, TM Stokley, S Zhao, Z
Citation: Dl. Bartlett et al., Comparison of NIS and NHIS/NIPRCS vaccination coverage estimates, AM J PREV M, 20(4), 2001, pp. 25-27
Prognostic value of initial pasting serum gastrin levels in patients with Zollinger-Ellison syndrome
Authors: Berger, AC Gibril, F Venzon, DJ Doppman, JL Norton, JA Bartlett, DL Libutti, SK Jensen, RT Alexander, HR
Citation: Ac. Berger et al., Prognostic value of initial pasting serum gastrin levels in patients with Zollinger-Ellison syndrome, J CL ONCOL, 19(12), 2001, pp. 3051-3057
Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer
Authors: Bartlett, DL Libutti, SK Figg, WD Fraker, DL Alexander, HR
Citation: Dl. Bartlett et al., Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer, SURGERY, 129(2), 2001, pp. 176-187
Yaba-like disease virus: An alternative replicating poxvirus vector for cancer gene therapy
Authors: Hu, Y Lee, J McCart, JA Xu, H Moss, B Alexander, HR Bartlett, DL
Citation: Y. Hu et al., Yaba-like disease virus: An alternative replicating poxvirus vector for cancer gene therapy, J VIROLOGY, 75(21), 2001, pp. 10300-10308
Nesidioblastosis in adults: A clinical enigma
Authors: Hirshberg, B Alexander, HR Bartlett, DL Skarulis, MC Libutti, SK Gorden, P
Citation: B. Hirshberg et al., Nesidioblastosis in adults: A clinical enigma, J CLIN END, 86(5), 2001, pp. 2329-2329
Gallbladder cancer
Authors: Bartlett, DL
Citation: Dl. Bartlett, Gallbladder cancer, SEM SURG ON, 19(2), 2000, pp. 145-155
Treatment of patients with hepatic metastases
Authors: Bartlett, DL
Citation: Dl. Bartlett, Treatment of patients with hepatic metastases, CANCER J, 6, 2000, pp. S169-S176
Stabilization policy in post-Soviet Armenia
Authors: Bartlett, DL
Citation: Dl. Bartlett, Stabilization policy in post-Soviet Armenia, POST-SOV GE, 41(1), 2000, pp. 30-47
A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver
Authors: Alexander, HR Libutti, SK Bartlett, DL Puhlmann, M Fraker, DL Bachenheimer, LC
Citation: Hr. Alexander et al., A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver, CLIN CANC R, 6(8), 2000, pp. 3062-3070
Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies
Authors: Libutti, SK Bartlett, DL Fraker, DL Alexander, HR
Citation: Sk. Libutti et al., Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies, J AM COLL S, 191(5), 2000, pp. 519-530
Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression
Authors: McCart, JA Puhlmann, M Lee, J Hu, Y Libutti, SK Alexander, HR Bartlett, DL
Citation: Ja. Mccart et al., Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression, GENE THER, 7(14), 2000, pp. 1217-1223
Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of athymidine kinase-deleted mutant
Authors: Puhlmann, M Brown, CK Gnant, M Huang, J Libutti, SK Alexander, HR Bartlett, DL
Citation: M. Puhlmann et al., Vaccinia as a vector for tumor-directed gene therapy: Biodistribution of athymidine kinase-deleted mutant, CANC GENE T, 7(1), 2000, pp. 66-73
Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease
Authors: Libutti, SK Choyke, PL Alexander, HR Glenn, G Bartlett, DL Zbar, B Lubensky, I McKee, SA Maher, ER Linehan, WM Walther, MM
Citation: Sk. Libutti et al., Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease, SURGERY, 128(6), 2000, pp. 1022-1027
Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas
Authors: Feingold, DL Alexander, HR Chen, CC Libutti, SK Shawker, TH Simonds, WF Marx, SJ Skarulis, MC Doppman, JL Schrump, DS Bartlett, DL
Citation: Dl. Feingold et al., Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomas, SURGERY, 128(6), 2000, pp. 1103-1109
Forty-eight-hour fast: The diagnostic test for insulinoma
Authors: Hirshberg, B Livi, A Bartlett, DL Libutti, SK Alexander, HR Doppman, JL Skarulis, MC Gorden, P
Citation: B. Hirshberg et al., Forty-eight-hour fast: The diagnostic test for insulinoma, J CLIN END, 85(9), 2000, pp. 3222-3226
Preaching to Galatians
Authors: Bartlett, DL
Citation: Dl. Bartlett, Preaching to Galatians, INTERPRETAT, 54(3), 2000, pp. 279-292
Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice
Authors: Feldman, AL Restifo, NP Alexander, HR Bartlett, DL Hwu, P Seth, P Libutti, SK
Citation: Al. Feldman et al., Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice, CANCER RES, 60(6), 2000, pp. 1503-1506
National Cancer Institute experience with regional therapy for unresectable primary and metastatic cancer of the liver or peritoneal cavity
Authors: Alexander, HR Bartlett, DL Libutti, SK
Citation: Hr. Alexander et al., National Cancer Institute experience with regional therapy for unresectable primary and metastatic cancer of the liver or peritoneal cavity, CUR CLIN ON, 2, 2000, pp. 127-150
Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases
Authors: Gnant, MFX Noll, LA Irvine, KR Puhlmann, M Terrill, RE Alexander, HR Bartlett, DL
Citation: Mfx. Gnant et al., Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases, J NAT CANC, 91(20), 1999, pp. 1744-1750
Heterogeneous gland size in sporadic multiple gland parathyroid hyperplasia
Authors: Berger, AC Libutti, SK Bartlett, DL Skarulis, MG Marx, SJ Spiegel, AM Doppman, JL Alexander, HR
Citation: Ac. Berger et al., Heterogeneous gland size in sporadic multiple gland parathyroid hyperplasia, J AM COLL S, 188(4), 1999, pp. 382-389
Isolated organ perfusion does not result in systemic microembolization of tumor cells
Authors: Wu, PC McCart, A Hewitt, SM Turner, E Libutti, SK Bartlett, DL Alexander, HR
Citation: Pc. Wu et al., Isolated organ perfusion does not result in systemic microembolization of tumor cells, ANN SURG O, 6(7), 1999, pp. 658-663
Risultati: 1-25 | 26-44